Societa Italiana di Chirurgia ColoRettale Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03791775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

SICCR - Gaetano Gallo | Societa Italiana di Chirurgia ColoRettale

Active Ingredients

Drugs in Phase 2 Trials (1)

polidocanol (asclera) (1 trial)

Drugs in Other Trials (1)

mesoglycan (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhoids (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2